baber/WOPTO huggingface dataset:
Patent PT-1026291-E (PT)
Inventor: LEGRAND EMMANUEL
IPC: A01K91/00
Filed: 2000-01-20
Abstract: The line (1) consists of a main filament (2) of a synthetic material, containing reinforcing particles forming between 0.5-5%, and preferably about 1% of its total mass. The particles are present both on the outer surface of the line and inside it.
Patent PT-1179035-E (PT)
Inventor: DAVIES GERALD HOWARD
IPC: B05D3/10
Filed: 2000-03-17
Abstract: A process for primer coating of steel which is intended to be fabricated and overcoated, in which process the steel is primer coated with a primer coating comprising a silica or silicate binder, wherein the binder comprises an aqueous silica sol or alkali metal silicate having a SiO<SUB>2</SUB>/M<SUB>2</SUB>O mole ratio, where M represents total alkali metal and ammonium ions, of at least 6:1, and that after the primer coating has dried to the extent that it is touch dry it is treated with a solution which increases the film strength of the primer coating.
Patent PT-1228241-E (PT)
Inventor: ROTTER JEROME I
IPC: C12Q1/68
Filed: 2000-06-30
Abstract: Detecting a genetic predisposition in a human subject for non-responsiveness to statin drug treatment, comprising amplifying nucleic acids including a non-coding or untranslated region within the 3' end of the human lipoprotein lipase (LPL) gene from a tissue sample, and analyzing the products for homozygosity for a variant allele, is new.. Independent claims are also included for the following: (1) oligonucleotide primers for detecting a genetic predisposition for non-responsiveness to statin drug treatment in a human, where the primers include: (a) one of 55 forward primers comprising a 17, 18, 19, 20, 21, 22, 24, 25, 26 or 28 base pair sequence, or comprising a sequence overlapping any of the sequences with respect to its position on the Nickerson reference sequence comprising a 9734 base pair sequence, all fully defined in the specification; (b) one of 7 forward primers comprising a 20, 21, 22 or 25 base pair sequence, or comprising a sequence overlapping any of the sequences with respect to its position on the Oka reference sequence, comprising a 3240 base pair sequence, all fully defined in the specification; (c) one of 35 reverse primers comprising a 15, 17, 20, 21, 22, 24, 25 or 26 base pair sequence all fully defined in the specification, or comprising a sequence overlapping any of the sequences with respect to its position on the Nickerson reference sequence; or (d) one of 5 reverse primers comprising a 23, 24 or 25 base pair sequence all fully defined in the specification, or comprising a sequence overlapping any of the sequences with respect to its position on the Oka reference sequence; and (2) genetic testing kits comprising the primers of (1).
Patent PT-1336605-E (PT)
Inventor: ISHIHARA TSUKASA
IPC: A61P7/02
Filed: 2001-11-21
Abstract: There are provided compounds having an anticoagulant action on the basis of inhibition of activated blood coagulation factor X and being useful as anticoagulants or preventive/therapeutic agents for diseases induced by thrombosis or embolism. Effective ingredients are the compounds such as 4'-bromo-2'-Ä(5-chloro-2-pyridyl)carbamoyl)-6- beta -D-galactopyranosyloxy-1-isopropylpiperidine-4-carboxanilide, 2'-(2-acetamido-2-deoxy- beta -D-glucopyranosyloxy)-4'-bromo-6'-Ä(5-chloro-2-pyridyl)carbamoylÜ-1-is opropylpiperidine-4-carboxanilide, etc. or salts thereof.
Patent PT-1308554-E (PT)
IPC: D21G7/00
Filed: 1994-02-25
Abstract: A single vessel digester system for digesting cellulosic fibrous material comprises a substantially upright vessel (221) having a top (220) and bottom (222) with a slurry of comminuted cellulosic material to be digested introduced adjacent the top (220), and pulp withdrawn adjacent the bottom (222); the vessel having a continuous cooking zone disposed at a first level of said digester (221), and including a first screen (225) for removing liquor from the cooking zone and a cooking circulation loop (230, 235, 238, 239) associated with said first screen (225) for circulating removed liquor to the interior of said digester (221) near the vicinity of said first screen (225); and an extraction screen (245) with extraction conduit (246) located at a second vertical level in said vessel (221), below said first level, and having means for adding dilution liquid (241; 242), having a lower dissolved organic material concentration than the liquor removed in said cooking circulation loop (230, 235, 238, 239), to said cooking circulation loop (230, 235, 238, 239), to reduce the concentration of DOM in the digester and thereby increase the strength of the pulp so-produced.
Patent PT-1379246-E (PT)
Title: Nociceptin analogs
Inventor: CHEN ZHENGMING
IPC: A61K31/44
Filed: 2002-04-18
Abstract: Compounds of formula (IV) as ORL1 modulators for the treatment of pain.
Patent PT-1446978-E (PT)
Title: A telecommunications system and method for controlling privacy
Inventor: KOKKONEN PETRI
IPC: H04W4/02
Filed: 2002-10-09
Abstract: A telecommunications system comprises at least one user and provides a first entity for storing information defining a privacy profile for at least one user. A second entity is arranged to store an association between at least one user and the first entity and the system is such that in response to a request for information relating to the user, the association stored in the second entity is used to identify the first entity so that a check can be made with respect to the privacy profile as to whether or not the requested information, can be provided.
Patent PT-1575904-E (PT)
Title: Method for the continuous production of isocyanates
Inventor: PENZEL ULRICH
IPC: C07C263/10
Filed: 2003-12-13
Abstract: The invention relates to a process for preparing polyisocyanates by reacting organic amines with phosgene, wherein the reaction is carried out in at least three stages, with the first stage being carried out in a mixing apparatus, the second stage in at least one residence apparatus and the third stage in at least one separation apparatus and the pressure in each successive stage being lower than that in the previous stage.
Patent PT-1575905-E (PT)
Title: Method for separating isocyanates out from a reaction mixture
Inventor: PENZEL ULRICH
IPC: C07C265/14
Filed: 2003-12-13
Abstract: The present invention relates to a process for preparing isocyanates by reaction of amines with phosgene in a reactor and subsequent separation of the isocyanate from the reaction mixture leaving the reactor and purification of the isocyanate, wherein the separation and purification of the isocyanate is carried out in a column having a pressure at the top of 1-950 mbar, preferably 5-50 mbar, particularly preferably 10-20 mbar, and a temperature at the bottom of 90-250° C., preferably 120-170° C., particularly preferably 130-150° C., and the pure isocyanate stream is preferably taken off in liquid or gaseous form at a side offtake of the column.
Patent PT-1502601-E (PT)
Title: Use of neurotoxin therapy for treatment of urinary retention
Inventor: SCHMIDT RICHARD A
IPC: A61P15/00
Filed: 1998-07-15
Abstract: The present application is directed to the use of a therapeutically effective amount botulinum toxin in the preparation of a pharmaceutical composition for treating a patient with a neurogenic bladder dysfunction, wherein the composition is to be administered by injection into a bladder wall of a patient with said neurogenic bladder dysfunction, thereby treating a symptom of said neurogenic bladder dysfunction.
Patent PT-1620327-E (PT)
Title: Intermediate bulk container
Inventor: THORPE JOHN RICHARD
IPC: B65D19/12
Filed: 2004-04-30
Abstract: An intermediate bulk container includes a flexible storage container, a rigid rectangular base member including a plurality of pole engaging formations on its upper surface which are arranged about its periphery, a plurality of poles, the lower end of each of which is releasably engageable with a pole engaging formation on the base so that the poles collectively provide a support cage for the storage container, a rigid pole location member (10) which includes a central opening through which the support container may be filled and a plurality of pole engaging formations with which the upper ends of the poles are releasably engageable, and bracing elements connecting a pair of poles on at least two adjacent sides of the cage to each other for holding the poles, in the planes in which they are located in the assembled container, perpendicular to the base and pole locating member.
Patent PT-1684898-E (PT)
Title: Adsorption material and process for its production
Inventor: LINDGREN GOERAN
IPC: B01J/
Filed: 2004-11-18
Abstract: An adsorption material and a process for retention of heavy metals from acqueous solutions and a process for production of the material are disclosed. The production process comprises a pre-treatment to cause covalent bonding of polyethylene-imine to cellulosic material. A filter unit and a filter device are also claimed.
Patent PT-1923073-E (PT)
Title: Combination medication comprising a pde-5 inhibitor
Inventor: KREISEL WOLFGANG
IPC: A61K38/095
Filed: 2004-06-03
Abstract: Phosphodiesterase type 5 inhibitor (I) is used to prevent or treat portal hypertension and associated disorders. Phosphodiesterase type 5 inhibitor (I) is used to prevent or treat portal hypertension; to prevent or treat hemorrhagic complications of portal hypertension, hepatorenal syndrome, hepatopulmonary syndrome, hepatic encephalopathy, spontaneous bacterial peritonitis and ascites; to prevent or treat diseases that can be ameliorated or prevented by lowering portal vein pressure and/or increasing portal vein blood flow; for modulating the metabolism of a substance, where such modulation comprises increasing portal vein blood flow and thus increasing hepatic blood flow. An independent claim is also included for a combination medication for preventing or treating portal hypertension and/or disease states or risks associated with portal hypertension, comprising a phosphodiesterase type 5 inhibitor (II) and another agent active against portal hypertension. ACTIVITY : Hypotensive; Hepatotropic; Nephrotropic; Antiinflammatory; Antibacterial. MECHANISM OF ACTION : Phosphodiesterase type 5 inhibitor.
Patent PT-1832493-E (PT)
Title: System and method of verifying the integrity of a train
Inventor: LECHEVIN ERIC
IPC: B61L1/00
Filed: 2007-03-02
Abstract: The system has a communication unit (7) communicating with a detection unit (4) of a short railway circuit (3). The unit (4) detects presence/absence of the train on the circuit (3). A calculation unit (9) calculates the distance traveled by the train between an instant in which the train holds the circuit (3) and an instant in which the train releases the circuit (3). The distance is expressed in the form of a confidence interval so that the probability that the train has not traveled a distance included in the interval is lower than probability compatible with standard railway safety. An independent claim is also included for a method of verifying an integrity of a train of a determined length.
Patent PT-2207632-E (PT)
Title: Disposal of human remains
Inventor: SULLIVAN ALEXANDER
IPC: A61G17/00
Filed: 2008-10-03
Abstract: A coffin (130) for use in an alkaline hydrolysis process, the coffin comprising a dissolvable receptacle for a cadaver, the dissolvable receptacle being dissolvable in the alkaline hydrolysis process.
Patent PT-2234760-E (PT)
Title: Multifunction abrasive tool with hybrid bond
Inventor: RAMANATH SRINIVASAN
IPC: B24D3/02
Filed: 2008-12-05
Abstract: Abrasive tools and techniques are disclosed that can cut hard, brittle materials to relatively precise dimensions. The tools, which can include a hybrid bond of metal or metal alloy and a resin matrix together with fine abrasive grits, can be employed, for example, in mirror finish cutting applications, thereby enabling '1x' or 'single-pass' multi-function abrasive processes. The specific selection of resin and metal or metal alloy types is such that the tool is sufficiently brittle for the purpose of manufacture and durability, but ductile enough to withstand the grinding and handling stresses (an exemplary hybrid bond includes bronze and polyimide). Numerous tool types and applications will be apparent in light of this disclosure, including abrasive products for electronic device manufacturing such as thin 1A8 blades (single blade or multi-blade configuration).
Patent PT-668933-E (PT)
Inventor: LISHKO VALERYI K
IPC: A61K38/46
Filed: 1993-11-19
Abstract: The present invention describes methods for using methioninase as an antitumor reagent in anti-methionine chemotherapy. Specifically, methioninase is used to slow or stop cell division which can be enhanced with competitive inhibitors of methionine. In addition, methioninase can be used in combination with anti-mitotic agents to increase the therapeutic effectiveness of the anti-mitotic by inducing cell cycle synchronization.
Patent PT-792152-E (PT)
Inventor: PIKE MALCOLM CECIL
IPC: A61P15/00
Filed: 1995-11-21
Abstract: Compositions and methods for use in treating benign gynecological disorders, wherein an effective amount of an antiprogestational agent Äe.g., progesterone (progestin, progestogen, gestagen) antagonist or progesterone synthesis inhibitorÜ administered over a first period of time is combined with an effective amount of a progestogen for a second period of time. The antiprogestational agent is selected from single agents or mixture thereof. The progestogen is selected from single agents or mixtures of natural or synthetic progestogens. The formulations are effective as contraceptive agents and for treatment of benign gynecological disorders including uterine fibroids, premestrual syndrome, dysfunctional uterine bleeding, polycystic ovarian syndrome and endometriosis.
Patent PT-817748-E (PT)
Inventor: MADIGAN JOHN
IPC: B65B21/02
Filed: 1996-04-15
Abstract: An apparatus (10) for loading containers into basket-style bottom-loading carriers (3) has a container infeed mechanism; a carrier infeed supplier (30); a carrier feeder mechanism (50) for removing carriers from the carrier infeed supplier; a carrier timer-transport assembly (60 or 260) for receiving carriers (3) from the carrier infeed supplier and initiating transport of the carriers in synchronous parallel motion above the containers; a gripper (82) assembly for opening the carriers (3); a declination belt assembly (90) forming a pathway for receiving transversely extending bottom panels of said carriers and transporting said carriers downwardly over the groupings of containers; a seating assembly (120) for engaging tops of handles of carriers such that as the seating members rotate the bottommost seating member engages the respective tops of the handles of the carriers; and bottom-panel closure mechanisms (130, 140, 182) for placing the bottom panels together in locking relationship with respect to one another.
Patent PT-854693-E (PT)
Inventor: THOMPSON PAUL J
IPC: A61F2/90
Filed: 1996-08-12
Abstract: A tubular prosthesis comprises a plurality of strands integrated into an integrated structure (18, 92, 100, 114) including resilient and ductile structural strands (32, 94, 102, 112) formed of a structural material, each structural strand tending to assume a nominal shape when in a relaxed state subject to no external stress, being elastically deformable away from the nominal shape, and further being plastically deformable responsive to application of a force to the structural strand exceeding a yield stress of the structural material, being thereby adapted to acquire a curved selected nominal shape in lieu of an original nominal shape. The structural strands (32, 94, 102, 112), are plastically deformed before they are integrated into the integrated structure and thereby are altered to have respective curved selected nominal shapes, and further are selectively oriented within the integrated structure to impart to the integrated structure a tubular nominal configuration corresponding to said curved selected nominal strand shapes. <IMAGE>
Patent PT-883489-E (PT)
Inventor: REITERER FRANZ
IPC: B32B27/20
Filed: 1997-05-07
Abstract: The present invention pertains to a packaging element comprising a supporting material fitted, on its face turned opposite the package, with a layer presenting a marking area and, on its face turned to the package, with a rough surface coating. The coating roughness has a depth of 1 to 100 mum, which can be obtained by using granulous filling material. The rough surface packaging element is suited as a covering element, including for yoghurt, as well as in the production of labels for bottle finishes.
Patent PT-872239-E (PT)
Inventor: TOLLEFSON DENNIS GARY
IPC: A61K31/55
Filed: 1998-04-09
Abstract: The present invention provides a method for treating cerebral focal stroke comprising administering a therapeutically effective dosage of olanzapine or a pharmaceutically acceptable salt or solvate thereof.
Patent PT-931247-E (PT)
Inventor: KETTLER WILHELM H
IPC: G01N21/47
Filed: 1998-05-08
Abstract: PCT No. PCT/EP98/02699 Sec. 371 Date Jan. 11, 1999 Sec. 102(e) Date Jan. 11, 1999 PCT Filed May 17, 1998 PCT Pub. No. WO98/53285 PCT Pub. Date Nov. 26, 1998Process for calculating colour formulations of pigmented special-effect shades wherein i) for each pigment on which a colorant system is based a set of calibration panels is created, and the associated reflection factors are determined experimentally, ii) from the measured reflection factors for each pigment on which the colorant system is based, the optical material parameters are determined using a radiation transport model to describe the diffusion of light in particulate media, iii) from all the platelet-like special-effect pigments on which the colorant system is based and in each case a fixed quantity of one or more colouristically inert topology-influencing fillers, so-called pseudopigments are formed whose optical material parameters are likewise determined by way of a calibration scale, iv) and, the formulation components and pigments and/or associated pseudopigments from a colorant system being specified, the reflection spectra of a special-effect shade which is to be rematched are simulated mathematically by reference to the optical material parameters, using a suitable radiation transport model to describe the diffusion of light in particulate media, with the associated quantity resulting in respect of each pigment, each pseudopigment and the topology-influencing filler.
Patent PT-991669-E (PT)
Inventor: LARSEN PETER FROMHOLT
IPC: A23L29/231
Filed: 1998-06-18
Abstract: A method of providing selected fractions of high-esterified pectin, each having different functionalities, by consecutive extraction of a vegetable material with acidic aqueous solutions to obtain successive fractions of high-esterified pectin with increasing setting time. The vegetable material is optionally prior to being extracted subjected to an acid pre-treatment by heating it in a homogeneous mixture of water and a water-miscible organic solvent. The pectin fractions obtainable by the method have improved properties when used in the preparation of food products such as preserves and acidified milk products. The pectin fractions are also useful as starting materials in a method of obtaining deesterified and optionally amidated pectin fractions having additionally improved functional characteristics.
Patent PT-1036180-E (PT)
Title: Vaccine prepared with circovirus type b sequences related to piglet weight loss disease (pwd)
Inventor: JESTIN ANDRE
IPC: C12N5/02
Filed: 1998-12-04
Abstract: Nucleotide sequence comprising a 1759 bp genomic DNA sequence (I) of a porcine circovirus called MAP ("maladie de l'amaigrissement du porcelet"; piglet fatal wasting disease), is new. Also claimed are: (1) The nucleotide sequence of the porcine circovirus is: (a) a fragment of (I); (b) a nucleotide sequence homologous to the nucleotide sequence of (a); (c) a nucleotide sequence complementary to (I) or complementary to the nucleotide sequence of (a) or (b); (d) a nucleotide sequence capable of hybridizing under stringent conditions to the nucleotide sequence of (a), (b) or (c); (e) a nucleotide sequence comprising (I) or the nucleotide sequences of (a), (b), (c) or (d); (f) a modified nucleotide sequence comprising the nucleotide sequence of (a), (b), (c), (d) or (e). (2) polypeptide encoded by the nucleotide sequence of (1); (3) cloning and/or expression vectors containing the nucleotide sequences; (4) viral or pseudoviral particles generated from the vectors; (5) host cells transformed with the vectors or (pseudo)viral particles; (6) animals containing the transformed cells; (7) synthetic polypeptides obtained using the amino acid sequence of a polypeptide as in (1); (8) hybrid polypeptides comprising at least one sequence of a polypeptide as in (2) or (7) and a sequence of an immunogenic polypeptide; (9) nucleotide sequences encoding the hybrid polypeptides; (10) vectors containing a sequence as in (9); (11) a method for the detection of the porcine circovirus; (12) mono- or polyclonal antibodies or their fragments or chimeric antibodies capable of specifically recognising a polypeptide as in (2) or (7); and (13) compounds that are capable of binding to a polypeptide or nucleotide sequence as above or of recognising an antibody as in (12) and/or of modulating, inducing or inhibiting the expression of genes and/or of modifying the cellular replication of MAP circovirus or of inducing or inhibiting pathologies associated with MAP circovirus infection in pigs and are capable of being selected by a screening assay comprising contacting a compound with a polypeptide, nucleotide sequence or transformed cell as above or administering the compound to an animal as in (6) and determining the effect of the compound.
Patent PT-1117653-E (PT)
Inventor: CUMMING JOHN GRAHAM
IPC: A61P19/02
Filed: 1999-09-27
Abstract: The invention concerns amide derivatives of Formula (I), wherein: G is N or CH; R<1 >is a group such as hydroxy, halo, trifluoromethyl, C1-6alkyl and C1-6alkoxy; each of R<2 >and R<3 >is hydrogen, halo, C1-6alkyl, C2-6alkenyl or C2-6alkynyl; R<4 >is a group such as hydrogen, hydroxy, C1-6alkyl, C1-6alkoxy and C3-7cycloalkyl, or R<4 >is of the Formula (IC): -K-J, wherein J is aryl, heteroaryl or heterocyclyl and K is a bond or a group such as oxy and imino, R<5 >is a group such as hydrogen, halo and trifluoromethyl; m is 1-3 and q is 0-4; or pharmaceutically acceptable salts or in vivo cleavable esters thereof; processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of diseases or medical conditions mediated by cytokines.
Patent SG-62489-G (SG)
Title: Stacked double density memory module using industry standard memory chips,double density memory board and method of forming a stacked double density memory module
IPC: G11C5/00
Filed: 1989-09-09
Abstract: A stacked double density memory module (30) may be formed from two industry standard memory chips (20, 25), by jumpering the no-connect (1) and chip enable (4) pins on one chip (20) and then stacking the jumpered chip on the other chip (25) with the pins on the jumpered (top) chip contacting the corresponding pins on the other (bottom) chip except for the chip select pins (4). In a preferred embodiment for use with 64K or one megabit DRAMs, the top chip is jumpered with a U-shaped strap (22) which runs from the no-connect pin (1) to the chip enable pin (4). The chip enable pin (4) is bent toward the chip body to retain the strap (22) in place. The technique may also be employed for stacking other industry standard memory or array chips.